Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 70Rectal Neoplasms 67Colorectal Neoplasms 61Breast Neoplasms 26Pancreatic Neoplasms 15Head and Neck Neoplasms 13Neoplasm Metastasis 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Unspecified Adult Solid Tumor, Protocol Specific 9Stomach Neoplasms 8Urinary Bladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Adenocarcinoma Of Esophagus 5Ovarian Neoplasms 4Kidney Neoplasms 4Gallbladder Neoplasms 4Bile Duct Neoplasms 4Peritoneal Neoplasms 3Oropharyngeal Neoplasms 3Neoplasms 3Nasopharyngeal Neoplasms 3Lymphoma 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Anus Neoplasms 3Uterine Cervical Dysplasia 2Salivary Gland Neoplasms 2

Interventions

pazopanib 1cixutumumab 1Streptozocin 1Salts 1Pantoprazole 1Omeprazole 1Octreotide 1Interferons 1Fluorouracil 1Everolimus 1Doxorubicin 1Acetates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Zollinger-Ellison Syndrome × Fluorouracil × Clear all
NCT00001165 2008-03-04

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
999 enrolled

Adenoma, Islet Cell, Neoplasm Metastasis, Zollinger-Ellison Syndrome, Gastrinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡